Obesity Facts and Their Influence on Renal Function Across the Life Span

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Citação
FRONTIERS IN MEDICINE, v.8, article ID 704409, 10p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Obesity is a chronic disease, with a rapidly increasing prevalence worldwide. Body mass index (BMI) provides the most useful population-level measure of overweight and obesity. For adults, overweight is defined as a BMI (Kg/m(2)) >= 25, and obesity as a BMI >= 30, for non-Asians and >= 27.5 for Asians. Abdominal obesity can be defined as a waist circumference equal to or higher than 102 cm for men and >= 88 cm for women. The definition of children and adolescents BMI changes with age and sex. Obesity may be exogenous or endogenous obesity, the latter is multifactorial and predominantly manifested during childhood. Presently, overweight and obesity are linked to more deaths worldwide than underweight. The total kidney glomerular filtration rate (GFR) is determined by the sum of nephrons and the GFR within each nephron or single nephron GFR. In clinical practice, GFR is more frequently calculated by GFR estimating equations based upon the plasma levels of creatinine, cystatin C, or both. The measured value of plasma creatinine is strongly influenced by non-GFR factors, by its tubular and gastrointestinal secretion, and by the problems associated with the lack of standardization of creatinine's laboratory assay discrediting it as an ideal GFR biomarker. Unlike creatinine, cystatin C plasma levels are mainly determined by GFR. Obesity may affect the kidney, via development of systemic arterial hypertension and/or diabetes mellitus, or directly, by ectopic accumulation of adipose tissue in the kidney. As obesity is a clinical condition associated with altered body composition, creatinine may not be the ideal biomarker for GFR measurement in obese individuals.
Palavras-chave
obesity, glomerular filtration rate, creatinine, cystatin C, pediatric, adult
Referências
  1. Aggarwal B, 2018, INDIAN J PEDIATR, V85, P463, DOI 10.1007/s12098-017-2531-x
  2. Andersen TB, 2009, PEDIATR NEPHROL, V24, P929, DOI 10.1007/s00467-008-0991-y
  3. Archer E, 2018, PROG CARDIOVASC DIS, V61, P89, DOI 10.1016/j.pcad.2018.06.002
  4. Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159
  5. Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4
  6. Bjork J, 2020, SCAND J CLIN LAB INV, V80, P456, DOI 10.1080/00365513.2020.1774641
  7. Blufpand HN, 2013, J PEDIATR-US, V163, P1722, DOI 10.1016/j.jpeds.2013.08.031
  8. Bokenkamp A, 1998, PEDIATRICS, V101, P875, DOI 10.1542/peds.101.5.875
  9. Bouvet Y, 2006, PEDIATR NEPHROL, V21, P1299, DOI 10.1007/s00467-006-0145-z
  10. Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144
  11. CDC Clinical Growth Charts, 2000, ATL GEORG
  12. Chang AR, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5301
  13. Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657
  14. Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240
  15. Correia-Costa L, 2016, PEDIATR NEPHROL, V31, P1321, DOI 10.1007/s00467-016-3367-8
  16. COUNAHAN R, 1976, ARCH DIS CHILD, V51, P875, DOI 10.1136/adc.51.11.875
  17. D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75
  18. De Souza V, 2015, EUR J PEDIATR, V174, P1225, DOI 10.1007/s00431-015-2523-7
  19. de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8
  20. Delanaye P, 2019, J AM SOC NEPHROL, V30, P1785, DOI 10.1681/ASN.2019030238
  21. den Bakker E, 2018, PEDIATR NEPHROL, V33, P1553, DOI 10.1007/s00467-018-3973-8
  22. den Bakker E, 2017, CLIN CHIM ACTA, V474, P38, DOI 10.1016/j.cca.2017.09.004
  23. Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1
  24. Di Bonito P, 2021, J RENAL NUTR, V31, P586, DOI 10.1053/j.jrn.2020.11.005
  25. FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
  26. Filler G, 2003, PEDIATR NEPHROL, V18, P981, DOI 10.1007/s00467-003-1271-5
  27. Finney H, 2000, ARCH DIS CHILD, V82, P71, DOI 10.1136/adc.82.1.71
  28. Fischbach M, 2002, PEDIATR NEPHROL, V17, P104, DOI 10.1007/s00467-001-0777-y
  29. Galteau MM, 2001, CLIN CHEM LAB MED, V39, P850, DOI 10.1515/CCLM.2001.141
  30. Grubb A, 2014, CLIN CHEM, V60, P974, DOI 10.1373/clinchem.2013.220707
  31. Grubb A, 2012, SCAND J CLIN LAB INV, V72, P73, DOI 10.3109/00365513.2011.634023
  32. Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006
  33. Harmoinen A, 2000, PEDIATR NEPHROL, V15, P105, DOI 10.1007/s004670000421
  34. Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248
  35. Jastreboff AM, 2019, OBESITY, V27, P7, DOI 10.1002/oby.22378
  36. Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112
  37. Khadilkar A, 2014, J PEDIATR-US, V164, P1358, DOI 10.1016/j.jpeds.2014.02.018
  38. Khandelwal P, 2014, J DEV ORIG HLTH DIS, V5, P189, DOI 10.1017/S2040174414000178
  39. La Scola C, 2020, J RENAL NUTR, V30, P261, DOI 10.1053/j.jrn.2019.07.003
  40. Larsson A, 2004, SCAND J CLIN LAB INV, V64, P25, DOI 10.1080/00365510410003723
  41. Le Bricon T, 2000, CLIN CHEM, V46, P1206
  42. Leion F, 2017, SCAND J CLIN LAB INV, V77, P338, DOI 10.1080/00365513.2017.1324175
  43. Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004
  44. Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
  45. Liu BY, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n365
  46. Marzuillo P, 2021, J UROLOGY, V205, P1466, DOI 10.1097/JU.0000000000001524
  47. Marzuillo P, 2018, J RENAL NUTR, V28, P359, DOI 10.1053/j.jrn.2018.01.001
  48. Mehta SK, 2015, CLIN PEDIATR, V54, P652, DOI 10.1177/0009922814557784
  49. Mian AN, 2017, ADV CHRONIC KIDNEY D, V24, P348, DOI 10.1053/j.ackd.2017.09.011
  50. Nehus EJ, 2017, KIDNEY INT, V91, P451, DOI 10.1016/j.kint.2016.09.031
  51. Norden AGW, 2001, KIDNEY INT, V60, P1885, DOI 10.1046/j.1523-1755.2001.00016.x
  52. Nyman U, 2009, SCAND J CLIN LAB INV, V69, P619, DOI 10.1080/00365510902946992
  53. Pottel H, 2008, CLIN CHIM ACTA, V396, P49, DOI 10.1016/j.cca.2008.06.017
  54. Pottel H, 2021, ANN INTERN MED, V174, P183, DOI [10.7326/M20-4366, 10.7326/L21-0248]
  55. Pottel H, 2016, NEPHROL DIAL TRANSPL, V31, P798, DOI 10.1093/ndt/gfv454
  56. Pottel H, 2012, PEDIATR NEPHROL, V27, P973, DOI 10.1007/s00467-011-2081-9
  57. Qiao Q, 2010, EUR J CLIN NUTR, V64, P23, DOI 10.1038/ejcn.2009.92
  58. Renganathan A, 2021, PEDIATR NEPHROL, V36, P1709, DOI 10.1007/s00467-020-04543-1
  59. Rhee CM, 2016, CURR OPIN NEPHROL HY, V25, P208, DOI 10.1097/MNH.0000000000000212
  60. Schwartz GJ, 2012, KIDNEY INT, V82, P445, DOI 10.1038/ki.2012.169
  61. Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287
  62. Schwartz GJ, 2009, PEDIATR NEPHROL, V24, P113, DOI 10.1007/s00467-008-0957-0
  63. SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571
  64. SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259
  65. Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821
  66. Soveri I, 2014, AM J KIDNEY DIS, V64, P411, DOI 10.1053/j.ajkd.2014.04.010
  67. Speeckaert MM, 2012, CLIN CHEM LAB MED, V50, P1597, DOI 10.1515/cclm-2012-0033
  68. Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018
  69. Styne DM, 2017, J CLIN ENDOCR METAB, V102, P709, DOI 10.1210/jc.2016-2573
  70. van Dam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40767-4
  71. Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85
  72. Wang Y, 2002, EUR J CLIN NUTR, V56, P973, DOI 10.1038/sj.ejcn.1601415
  73. Wuerzner G, 2011, OBESITY FACTS, V4, P238, DOI 10.1159/000329547
  74. Xiao NZ, 2014, OBESITY, V22, P2319, DOI 10.1002/oby.20870
  75. Zappitelli M, 2006, AM J KIDNEY DIS, V48, P221, DOI 10.1053/j.ajkd.2006.04.085
  76. Zhu QZ, 2018, NAT REV NEPHROL, V14, P105, DOI 10.1038/nrneph.2017.157